Physician profile
Robert A Campbell
NPI 1063412823
$1,018.28
in general payments reported to CMS, 2019-2025
16 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $88.43 · 2021: $58.95 · 2022: $41.88 · 2023: $144 · 2024: $261 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $538.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $188.59 | 2019-2024 | |
| Novo Nordisk INC | $188.29 | 2019-2025 | Ozempic |
| Astrazeneca Pharmaceuticals LP | $129.81 | 2019-2025 | Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $95.39 | 2019-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $79.14 | 2022-2025 | Pifeltro |
| Viiv Healthcare Company | $57.46 | 2024-2025 | Dovato |
| Abbvie INC. | $48.28 | 2023 | Vraylar |
| Lilly USA, LLC | $39.91 | 2024 | Mounjaro |
| Boston Scientific Corporation | $38.93 | 2019 | |
| Gilead Sciences, INC. | $28.87 | 2019 | |
| Janssen Biotech, INC. | $26.97 | 2020-2023 | Symtuza |
| Sanofi Pasteur INC. | $23.43 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $19.52 | 2023 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $19.46 | 2024 | |
| Exact Sciences Corporation | $18.10 | 2024 | Cologuard Collection Kit |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.